These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17505081)

  • 1. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate.
    Newhauser W; Fontenot J; Koch N; Dong L; Lee A; Zheng Y; Waters L; Mohan R
    Phys Med Biol; 2007 Jun; 52(11):2937-52. PubMed ID: 17505081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.
    Newhauser WD; Koch NC; Fontenot JD; Rosenthal SJ; S Gombos D; Fitzek MM; Mohan R
    Phys Med Biol; 2007 Jul; 52(13):3979-90. PubMed ID: 17664589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.
    Cheung J; Kudchadker RJ; Zhu XR; Lee AK; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7135-47. PubMed ID: 21076190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy.
    Paganetti H; Jiang H; Parodi K; Slopsema R; Engelsman M
    Phys Med Biol; 2008 Sep; 53(17):4825-53. PubMed ID: 18701772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.
    Giebeler A; Fontenot J; Balter P; Ciangaru G; Zhu R; Newhauser W
    J Appl Clin Med Phys; 2009 Jan; 10(1):2875. PubMed ID: 19223836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy.
    Ahn SH; Gil MS; Lee DS; Han Y; Park HC; Sohn JW; Kim HY; Shin EH; Yu JI; Noh JM; Cho JS; Ahn SH; Choi DH
    Med Phys; 2015 May; 42(5):2626-37. PubMed ID: 25979054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy.
    Vassiliev ON; Kudchadker RJ; Kuban DA; Frank SJ; Choi S; Nguyen Q; Lee AK
    Phys Med; 2012 Jul; 28(3):240-4. PubMed ID: 21875820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.
    Newhauser W; Fontenot J; Zheng Y; Polf J; Titt U; Koch N; Zhang X; Mohan R
    Phys Med Biol; 2007 Aug; 52(15):4569-84. PubMed ID: 17634651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental measurements and Monte Carlo simulations for dosimetric evaluations of intrafraction motion for gated and ungated intensity modulated arc therapy deliveries.
    Oliver M; Gladwish A; Staruch R; Craig J; Gaede S; Chen J; Wong E
    Phys Med Biol; 2008 Nov; 53(22):6419-36. PubMed ID: 18941277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of electron beam obliquity on lateral buildup ratio: a Monte Carlo dosimetry evaluation.
    Chow JC; Grigorov GN
    Phys Med Biol; 2007 Jul; 52(13):3965-77. PubMed ID: 17664588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beams.
    Herrmann R; Carl J; Jäkel O; Bassler N; Petersen JB
    Acta Oncol; 2010 Oct; 49(7):1160-4. PubMed ID: 20831508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental validation of a Monte Carlo proton therapy nozzle model incorporating magnetically steered protons.
    Peterson SW; Polf J; Bues M; Ciangaru G; Archambault L; Beddar S; Smith A
    Phys Med Biol; 2009 May; 54(10):3217-29. PubMed ID: 19420426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic gold particle-based fiducial markers for proton therapy of prostate cancer.
    Lim YK; Kwak J; Kim DW; Shin D; Yoon M; Park S; Kim JS; Ahn SH; Shin J; Lee SB; Park SY; Pyo HR; Kim DY; Cho KH
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1609-16. PubMed ID: 19616746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study.
    Matsuura T; Maeda K; Sutherland K; Takayanagi T; Shimizu S; Takao S; Miyamoto N; Nihongi H; Toramatsu C; Nagamine Y; Fujimoto R; Suzuki R; Ishikawa M; Umegaki K; Shirato H
    Med Phys; 2012 Sep; 39(9):5584-91. PubMed ID: 22957624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment.
    Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers.
    Landry G; Reniers B; Lutgens L; Murrer L; Afsharpour H; de Haas-Kock D; Visser P; van Gils F; Verhaegen F
    Med Phys; 2012 Mar; 39(3):1410-7. PubMed ID: 22380373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt gamma-ray emission from biological tissues during proton irradiation: a preliminary study.
    Polf JC; Peterson S; Ciangaru G; Gillin M; Beddar S
    Phys Med Biol; 2009 Feb; 54(3):731-43. PubMed ID: 19131673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the weighted CT dose index in modern multi-detector CT scanners.
    Perisinakis K; Damilakis J; Tzedakis A; Papadakis A; Theocharopoulos N; Gourtsoyiannis N
    Phys Med Biol; 2007 Nov; 52(21):6485-95. PubMed ID: 17951857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.